Related Experiment Video
Updated: Oct 25, 2025
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Effect of a smartphone application (Perx) on medication adherence and clinical outcomes: a 12-month randomised
Ang Li1,2, M Gail Del Olmo3,4, Mackenzie Fong3
1Boden Collaboration, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia ang.li5@unimelb.edu.au.
Objective:
To determine whether the Perx app improves medication adherence and clinical outcomes over 12 months compared with standard care in patients requiring polypharmacy.
Design:
Randomised controlled trial with 12-month follow-up.
Setting:
Outpatient clinics in three tertiary hospitals in Sydney, Australia.
Participants:
Eligible participants were aged 18-75 years, with at least one chronic condition, taking ≥3 different medications (oral medications or injections), with smartphone accessibility. Participants were randomised in a 1:1 ratio.
Interventions:
The intervention group used the Perx app that contained customised reminders and gamified interactions to reward verified medication adherence.
Main Outcome Measures:
The primary outcome was medication adherence over 12 months measured using pill counts. Secondary outcomes included clinical outcomes (haemoglobin A1c (HbA1c), cholesterol, blood glucose, triglycerides, creatinine, thyroid function, blood pressure and weight).
Results:
Of 1412 participants screened for eligibility, 124 participants were randomised; 45 in the Perx arm and 40 in the control arm completed the study. The average age was 59.5, 58.9% were women, chronic conditions were cardiovascular disease (78%), type 2 diabetes (75%), obesity (65%) or other endocrine disorders (18%). On average, participants were taking six medications daily. The Perx group had greater improvements in adherence at month 2 (Coef. 8%; 95% CI 0.01 to 0.15), month 3 (Coef. 7%; 95% CI 0.00 to 0.14) and month 12 (Coef. 7%; 95% CI 0.00 to 0.13). The probability of HbA1c ≤6.5% was greater in the Perx group at months 9 and 12 and cholesterol (total and low-density lipoprotein cholesterol) was lower in the Perx group at month 3. The intervention was particularly effective for those with obesity, taking medications for diabetes and taking ≤4 medications.
Conclusions:
This study provides evidence that app-based behavioural change interventions can increase medication adherence and produce longer-term improvements in some clinical outcomes in adults managing multimorbidity. More trials are needed to build the evidence base.
Trial Registration Number:
ACTRN12617001285347.
Related Concept Videos
01:54The Placebo Effect
01:28Drug Therapy
Antianxiety Medications
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:29Therapeutic Drug Monitoring: Affecting Factors
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...